NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value

February 13, 2024

https://www.globenewswire.com/news-release/2024/02/13/2828292/0/en/NeuroMetrix-Announces-Review-of-Strategic-Options-to-Promote-Growth-and-Maximize-Shareholder-Value.html

WOBURN, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq:NURO), a commercial stage medical device company focused on reducing the impact of neurological disorders and pain syndromes through innovative non-invasive medical devices, today announced a process to review strategic options to promote growth of its Quell® neuromodulation and DPNCheck® neurodiagnostic businesses and to maximize shareholder value.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.